Baker Bros. Raises Stake in Synageva BioPharma Corp (GEVA) Through Convention of Options

As a new form 4 filing with the Securities and Exchange Commission showed, Julian and Felix BakersBaker Bros Advisors, a fund focused on the biotechnology and healthcare companies, have revealed upping its long stake in Synageva BioPharma Corp (NASDAQ:GEVA). According to the filing, Baker Bros. have purchased close to 29,800 shares of the company at a price of $60.45 apiece. The price, which is much lower in comparison with the current stock price of Synageva BioPharma, was obtained following the conversion of the Non-Qualified Stock Options, held by the fund since 2005. In this way, currently, Baker Bros. owns almost 10.88 million shares of the company.

Synageva BioPharma

Earlier in April, Baker Bros has also converted options to purchase 56,000 shares of Synageva BioPharma Corp (NASDAQ:GEVA) at a price of $65.10 per share, held since 2007. In this way, Baker Bros. has solidified its position as one of the largest shareholders of the company.

The stock of Synageva BioPharma Corp (NASDAQ:GEVA) has surged by around 62% since the beginning of the year, and by 150% over the past year. The company has posted a significant net loss for the first quarter of the year, of $36.4 million, versus $14.5 million for the same period of the last year, while its revenue amounted to $1.6 million. According to a statement Synageva BioPharma Corp (NASDAQ:GEVA) is working on the development of its ARISE drug for Lysosomal Acid Lipase Deficiency treatment and plans to report top-line results from the Phase 3 trial during the third quarter of the year.

Other investors, among the funds we track, hold smaller positions in Synageva BioPharma. Jerome Pfund and Michael Sjostrom‘s Sectoral Asset Management owns 465,145 shares as of the end of March, down by 37% of the quarter. On the other hand, James E. Flynn‘s Deerfield Management and Donald Chiboucis‘ Columbus Circle Investors have initiated stakes in the company during the first quarter, reporting ownership of 317,700 shares and 186,300 shares of Synageva BioPharma Corp (NASDAQ:GEVA) respectively in their latest 13F filings.

Disclosure: none

blog comments powered by Disqus
Insider Monkey Headlines
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months Click to see monthly returns in table format!

Lists

The 10 Best-Selling Cars in 2014

The 10 Best Industries to Invest In

The 10 Most Expensive States to Own a Car In

Top 10 Business Schools in US: 2014 Rankings

Top 20 Female Billionaires in 2014

6 Movies That You Should Watch to Better Understand The Cold War

Top 15 Best Paying Jobs for Women in 2014

Top 6 Things Rich People Do Differently Every Day

5 Retirement Mistakes To Avoid (and Einstein’s Famous Quote)

11 Smartest People in the World

6 Films About the Financial World You Need To Watch (While “The Wolf” is Not Around)

Warren Buffett and Billionaires Are Crazy About These 7 Stocks

The Top 10 States With Fastest Internet Speeds

10 Best Places to Visit in USA in August

Top 10 Cities to Visit Before You Die

Top 10 Genetically Modified Food In the US

15 Highest Grossing Movies Opening Weekend

5 Best Poker Books For Beginners

10 Strategies Hedge Funds Use to Make Huge Returns

Top 10 Fast Food Franchises to Buy

10 Best Places to Visit in Canada

Best Summer Jobs for Teachers

10 Youngest Hedge Fund Billionaires

Top 10 One Hit Wonders of the 90s

Fastest Growing Cities In America

Top 10 U.S. Cities for Freelancers

Top 9 Most Popular Free iPhone Apps

Top 10 Least Expensive Private Business Schools in the US

Top 15 Most Expensive Countries in the World – 2014

Top 6 Tax Scams and How to Protect Yourself

Top Businesses to Invest In

Top 5 Things You Might Be Doing Wrong With Your Business

Top 5 Strategic Technology Trends in 2014

Top Rags to Riches Stories

Parenting Behavior That Promotes Future Leaders

Top 5 Mistakes Made by Small Businesses

Top 5 Most Common and Potentially Devastating Financial Blunders

Top 5 Highest Paying Jobs for Web Designers

Top 6 Most Respected Professions that Also Pay Well

Top 5 Pitfalls Investors Should Avoid

Top 6 Lawyers and Policy Makers Under 30

Top 6 New Year’s Resolutions for Entrepreneurs

Top 7 Locations to Check in on Facebook

Top 5 Mistakes made by Rookie eBay Sellers

Top 7 eBook Publishers in 2013

Top 6 Health Industry Trends in 2014

5 Lessons for Entrepreneurs from Seth Godin

Top 5 Success Tips from Jordan Belfort – the Wolf of Wall Street

Best Master’s in Finance Degree Programs

Top 6 Earning Celebrities Over 50

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!